AI assistant
KKR & Co. Inc. — Director's Dealing 2021
Apr 23, 2021
10262_dirs_2021-04-22_30b56a1d-11de-41bd-a875-e2d11ac9c51a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IMPEL NEUROPHARMA INC (IMPL)
CIK: 0001445499
Period of Report: 2021-04-22
Reporting Person: KKR Iris Investors LLC (N/A)
Reporting Person: KKR Healthcare Strategic Growth Fund L.P. (N/A)
Reporting Person: KKR Associates HCSG L.P. (N/A)
Reporting Person: KKR HCSG GP LLC (N/A)
Reporting Person: KKR Group Partnership L.P. (N/A)
Reporting Person: KKR Group Holdings Corp. (N/A)
Reporting Person: KKR & Co. Inc. (N/A)
Reporting Person: KKR Management LLP (N/A)
Reporting Person: KRAVIS HENRY R (N/A)
Reporting Person: ROBERTS GEORGE R (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series D Preferred Stock | $ | Common Stock (2583926) | Indirect |
Footnotes
F1: Each share of the Issuer's preferred stock is convertible on a 1-to-16.37332 basis into shares of the Issuer's Common Stock at the holder's election and has no expiration date. The preferred stock will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
F2: Securities held directly by KKR Iris Investors LLC ("KKR Iris"). KKR Health Care Strategic Growth Fund L.P. is the managing member of KKR Iris. KKR Associates HCSG L.P. is the general partner of KKR Health Care Strategic Growth Fund L.P. KKR HCSG GP LLC is the general partner of KKR Associates HCSG L.P. KKR Group Partnership L.P. is the sole member of KKR HCSG GP LLC. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR & Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP.
F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.